Oslo ,10 February 2023 -Observe Medical ASA ("the Company" or "Observe Medical ") will release its fourth quarter 2022 results on Friday,17 February 2023 . The presentation will be made available onNewsWeb and the Company's website at07:00 CET on the same day.Rune Nystad , CEO, and Per Arne Nygård, CFO, will host a presentation and Q&A session at08:30 CET on the day of the results. The presentation will take place at Haakon VIIs gate 2 and will be available via webcast at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20230217_3/ After the live event, the presentation and recording will be made available under the Investor Relations section on the Company's website, https://observemedical.com/investor-relations/. For further information, please contact:Rune Nystad , CEOObserve Medical Mobile: +47 916 24 683 E-mail: rune.nystad@observemedical.com Per Arne Nygård, CFO ofObserve Medical Mobile: +47 411 04 345 E-mail: perarne.nygard@observemedical.com AboutObserve Medical Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics. The Company seeks to drive growth by leveraging its expertise in sales and commercialisation of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A. The Company is headquartered inOslo, Norway , with additional offices in Narvik (Norway ),Gothenburg (Sweden ), Oulu (Finland ), andSeattle (the US). In addition,Observe Medical has a direct sale organisation in the Nordics and a distributor network internationally. Further information is available at www.observemedical.com.
Click here for more information
© Oslo Bors ASA, source